fda stopping compounded semaglutide warns about versions of semaglutide, used for diabetes, weight loss fda semaglutide shortage resolved february

10.1038/s41598-022-18098-8 253 StockertJ

While Retatrutide differs in its receptor profile, the general peptide structure and delivery method similarities provide reasonable grounds for optimism about long-term safety

Wilson JM, Nikooienejad A, Robins DA, Roell WC, Riesmeyer JS, Haupt A, Duffin KL, Taskinen MR, Ruotolo G

5,13 Clinical trials in obesity and non-alcoholic fatty liver disease suggest that multi-strain probiotic formulations can modestly improve anthropometric measures, lipid profiles, and, in some studies, increase GLP-1 concentrations

Fades signs of sun damage and hyperpigmentation as it brightens skin

Dietary salt consumption and inflammatory bowel disease